GlassScriptPhysician profile
Britney A Gibby
NPI 1326589359
$593.89
in general payments reported to CMS, 2019-2025
14 companies · $21.18 in 2025
The $21.18 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $251 · 2022: $245 · 2023: $52.39 · 2024: $24.97 · 2025: $21.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $165.92 | 2021-2023 | |
| Exeltis, USA INC. | $56.92 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $56.26 | 2021-2022 | |
| Hologic Sales and Service, LLC | $51.86 | 2022-2025 | Aptima, Thinprep 2000 Processor |
| Agile Therapeutics, INC. | $49.73 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $34.02 | 2021-2022 | |
| Evofem Biosciences, INC. | $32.36 | 2022 | |
| Organon LLC | $32.10 | 2021-2023 | Nexplanon |
| Astellas Pharma US INC | $24.97 | 2024 | Veozah |
| Scynexis, INC. | $20.46 | 2022 | |
| Coopersurgical, INC. | $18.38 | 2022 | |
| Daiichi Sankyo INC. | $17.78 | 2022 | |
| Currax Pharmaceuticals LLC | $17.19 | 2023 | Contrave, Onzetra Xsail |
| Bayer Healthcare Pharmaceuticals INC. | $15.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Britney Gibby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.